| AFTV | autologous formalin-fixed tumor vaccine |
| AHR | aryl hydrocarbon receptor |
| ATRX | α-thalassemia/mental retardation X-linked |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 |
| BRM | biological response modifier |
| CAR | chimeric antigen receptor |
| CMV | cytomegalovirus |
| CSF-1 | colony-stimulating factor-1 |
| CTLA-4 | cytotoxic T lymphocyte antigen-4 |
| DC | dendritic cell |
| EGFR | epidermal growth factor receptor |
| FOXP3 | forkhead box protein P3 |
| GARP | glycoprotein A repetitions predominant |
| GBM | glioblastoma |
| GSC | glioma stem cell |
| ICI | immune checkpoint inhibitor |
| ICM | immune checkpoint molecule |
| IDH | isocitrate dehydrogenase |
| IDO | indoleamine 2,3 dioxygenase |
| IL | interleukin |
| IL-7-hyFc | IL-7-hybrid-Fc recombinant protein |
| KPS | Karnofski performance status |
| LNP | lipid nanoparticle |
| M2Mφ | M2-type macrophage |
| MDSC | myeloid-derived suppressor cell |
| MGMT | O6-methylguanine-DNA methyltransferase |
| MIF | macrophage migration inhibitory factor |
| oHSV | oncolytic herpes simplex viruses |
| PD-1 | programmed cell death-1; PD-L1/2 programmed cell death ligand 1/2 |
| PDPN | podoplanin |
| PI3Kγ | phosphatidylinositol 3-kinase γ |
| PRMT 5 | protein arginine methyltransferase 5 |
| PMN | polymorphonuclear |
| PTEN | phosphatase and tensin homolog |
| RT | radiation therapy |
| TAM | tumor-associated macrophage |
| TAMC | tumor-associated bone marrow cell |
| TERT | telomerase reverse transcriptase |
| TIL | tumor-infiltrated lymphocyte |
| TIM-3 | T-cell immunoglobulin and mucin domain 3 |
| TMZ | temozolomide |
| Treg | regulatory T cell |
| VEGF | vascular endothelial growth factor |
| WHO | World Health Organization |